| 摘要 |
A galanin antagonist which is a galanin receptor ligand is described. Further, new peptides Galanin(1-12)-Pro-Substance P(5-11), Galanin(1-12)-Pro-Bradykinin(2-9), Galanin(1-12)-Pro-Pro-Pro-(Leu<5>-Enkephalin(5-1)), Galanin(1-12)-Pro-Lys( epsilon -NH-)Pro-(Leu<5>-Enkephalin(5-1)) and functional analogues and functional derivates thereof which exhibit substantially the same galanin antagonistic effect as said peptides are disclosed. Use of the galanin antagonist, a pharmaceutical preparation comprising it and a method of treating a disorder in a mammal which depends on the physiological function of galanin at the galanin receptor are also included. |
